Assessment of Saliva-Based Redox Biomarkers Among Patients with Oral Potentially Malignant Disorders: A Clinical Survey

Abstract

Oral potentially malignant disorders (OPMDs) represent a clinically significant category of oral mucosal conditions associated with an increased risk of malignant transformation. These disorders involve complex biological mechanisms, including epithelial alterations, chronic inflammation, oxidative imbalance, and disruption of cellular homeostasis. Conventional diagnosis of OPMDs primarily depends on clinical examination and histopathological evaluation; however, these approaches may not fully capture early molecular changes occurring before visible progression. Saliva-based redox biomarkers have emerged as promising non-invasive indicators capable of reflecting oxidative stress-related alterations within the oral environment. This clinical survey investigates the potential role of salivary redox biomarkers in assessing patients affected by oral potentially malignant disorders and evaluates their significance as complementary diagnostic indicators.

The study framework focuses on evaluating oxidative stress-related biochemical changes in saliva and understanding their association with clinically identified oral lesions. Redox imbalance occurs when reactive oxygen species generation exceeds antioxidant defense capacity, resulting in cellular damage, altered signaling mechanisms, and increased vulnerability of epithelial tissues. Saliva provides a practical diagnostic medium because it contains measurable biological components associated with oxidative processes and can be collected through minimally invasive procedures. Recent comparative evidence evaluating salivary oxidative stress markers in oral leukoplakia and oral submucous fibrosis has demonstrated the relevance of redox biomarkers in identifying disease-associated biochemical alterations (Chatterjee et al., 2026).

This investigation adopts a clinical survey approach integrating oral examination, biochemical assessment principles, and interpretation of redox-related changes. The conceptual model considers OPMDs as multifactorial conditions influenced by local tissue responses, environmental exposures, and systemic biological factors. Salivary biomarkers are evaluated as indicators of molecular imbalance that may support early risk assessment and disease monitoring.

The findings indicate that saliva-based redox evaluation has potential value as an adjunctive approach in oral healthcare. Although biomarkers alone cannot replace histopathological confirmation, their ability to provide molecular information may improve understanding of disease progression and support personalized monitoring strategies. The integration of biochemical assessment with emerging digital diagnostic technologies may further enhance future clinical applications.

The study highlights the importance of continued investigation into saliva-based diagnostic systems, emphasizing the need for standardized protocols, longitudinal studies, and broader clinical validation. By examining the relationship between oxidative stress and oral potentially malignant disorders, this research contributes to the development of minimally invasive approaches for improving early detection and management of oral disease.